Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results

Go back to Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results
(NASDAQ: GLUE) Delayed: 9.96 -0.16 (1.58%)
Previous Close $10.12    52 Week High $ 
Open $10.18    52 Week Low $ 
Day High $10.23    P/E N/A 
Day Low $9.88    EPS $ 
Volume 104,640